All posts

DTOL stock is a buy, Stifel says

Stifel analyst Suthan Sukumar has initiated coverage of D2L (D2L Stock Quote, Chart, News, Analysts, Financials TSX:DTOL) with a “Buy” rating and twelve-month price target of $14.00.

As reported by the Globe and Mail, the analyst thinks the ed-tech firm is well positioned.

“We believe a commitment to innovation and stronger go-to-market execution have elevated D2L’s competitive positioning in its core market of higher-ed, allowing it to capture nearly 50 per cent of global deal activity last year,” he wrote. “This inflection from the mid-teens in prior years is reinforced by consistent customer feedback that points to a compelling product/platform experience that helps bridge the gap with market-leader Canvas. While there is potential for a rebound in the K-12 market with anticipated Federal funding tailwinds, we see more opportunity with corporate learning and its intersection with higher-ed, alongside growing international penetration, to sustain accelerated double-digit organic growth with EBITDA and FCF expansion as well as line-of-sight to rule-of-40 longer-term.”

Sukumar explained his take on the stock’s valuation.

“D2L trades at 0.8 times calendar 2025 estimated Sales/5 times C25E EBITDA, vs. EdTech peers at 3 times/19 times and education LMS peers at 7 times/18 times, despite a pristine balance sheet and re-accelerating growth, profitability and cash flows,” he said. “While D2L doesn’t share the same scale opportunity of a high-growth D2C-model like DUOL at the high-end of EdTech peers (1-11 times), there are several small-cap names with comparable (or lower) growth and profitability at 1-2 times, which we think supports limited downside. Our $14/share target implies 2 times C25E Sales. We see multiple expansion with continued execution on growth and profitability upside, with a larger market cap supporting a further rerate to larger, more established LMS peers at 7 times as visibility improves to a rule-of-40 profile.”

At press time, shares of D2L were even at $7.30.

Tagged with: dtol
Staff

Recent Posts

Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]

2 hours ago

Haywood raises price target on KITS Eyecare to $21.00

Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]

10 hours ago

QBTS stock is still undervalued, this analyst says

Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]

11 hours ago

Rogers Communications wins price target raise at National Bank

Macro headwinds continue to affect the wireless business in Canada, but National Bank Financials analyst Adam Shine likes what he… [Read More]

1 day ago

A Canadian recession is unlikely, RBC says

Canada’s economy contracted modestly in April, with real GDP edging down 0.1% as U.S. trade disruptions led to a sharp… [Read More]

2 days ago

Air Canada stock is a buy, Citi says

Don't worry about it. That's the takeaway from a recent report by Citi analyst Stephen Trent on Air Canada (Air… [Read More]

4 days ago